what is glp 1 gip Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes The activity of GLP-1 and
Description
Diabetes therapies are generally understood to be lifelong, with adjustments over time
Confirmation the patient is not receiving PBS-subsidised SGLT2-i, DPP-4 i, or another GLP-1 RA.
The statements made herein are solely the responsibility of the authors
The research provides an extensive summary of the skin effects associated with GLP-1RA treatment, including adverse reactions and potential medical advantages
